Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound - Scorecard - MDSpire
Advertisement
Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound
Clinical Scorecard: Impact of Probe Pressure and Patient Position on the Diagnostic Precision of Quantitative Ultrasound for Hepatic Steatosis in Both Genders
At a Glance
Category
Detail
Condition
Metabolic dysfunction-associated steatotic liver disease (MASLD) with hepatic steatosis
Key Mechanisms
Quantitative ultrasound (QUS) attenuation imaging measures liver fat content by assessing ultrasound wave attenuation; influenced by probe pressure and patient body position
Target Population
Adults with or without MASLD, both men and women
Care Setting
Hospital-based diagnostic imaging, gastroenterology and hepatology departments
Key Highlights
MASLD prevalence is high globally, with significant mortality risk associated with hepatic steatosis.
Liver biopsy is invasive; MRI-PDFF is the non-invasive reference standard for liver fat quantification but has accessibility limitations.
Quantitative ultrasound using the ultrasound-guided attenuation parameter (UGAP) offers a non-invasive method to assess liver fat, but diagnostic accuracy may be affected by probe pressure, patient position, and sex.
Guideline-Based Recommendations
Diagnosis
Use MRI-PDFF as the reference standard for hepatic fat quantification when available.
Conventional ultrasound is recommended for MASLD diagnosis but has limited sensitivity in early steatosis stages.
Quantitative ultrasound (UGAP) can be used to assess liver fat content non-invasively, considering probe pressure and patient positioning.
Management
Ensure patient fasting for at least 5 hours before ultrasound examination.
Perform UGAP measurements with standardized probe pressure (normal 4 N) and body position (supine or 30° left decubitus) to optimize reliability.
Monitoring & Follow-up
Repeat UGAP measurements to assess reliability, ideally with the same operator blinded to prior results.
Use median values of multiple measurements with quality control criteria (interquartile range to median ratio < 30%) for accuracy.
Risks
Liver biopsy carries risks of adverse events and should be replaced by non-invasive methods when possible.
Increased probe pressure or improper patient positioning may reduce diagnostic accuracy of QUS.
Patient & Prescribing Data
Adults with clinically verified MASLD or low-risk healthy controls
UGAP measurements require standardized technique including probe force and patient positioning to ensure diagnostic precision; sex differences in fat distribution may necessitate sex-specific thresholds.
Clinical Best Practices
Standardize probe pressure at approximately 4 Newtons during UGAP measurements.
Position patients supine or at 30° left decubitus with right arm elevated to optimize liver ultrasound window.
Use multiple UGAP measurements and quality maps to confirm reliability and reduce variability.
Consider sex-specific differences in hepatic fat distribution when interpreting UGAP results.
Perform UGAP and MRI-PDFF on the same day when possible to correlate findings.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
